Viatris (VTRS) Revenue Growth (1y) (2020 - 2026)
Viatris (VTRS) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 14.92% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 333.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.85% |
| Dec 31, 2025 | 7.43% |
| Sep 30, 2025 | 0.23% |
| Jun 30, 2025 | -5.73% |
| Mar 31, 2025 | -11.17% |
| Dec 31, 2024 | -8.35% |
| Sep 30, 2024 | -4.64% |
| Jun 30, 2024 | -3.39% |
| Mar 31, 2024 | -1.76% |
| Dec 31, 2023 | -2.89% |
| Sep 30, 2023 | -3.28% |
| Jun 30, 2023 | -4.55% |
| Mar 31, 2023 | -10.75% |
| Dec 31, 2022 | -11.18% |
| Sep 30, 2022 | -10.02% |
| Jun 30, 2022 | -10.00% |
| Mar 31, 2022 | -5.04% |
| Dec 31, 2021 | 21.54% |
| Mar 31, 2021 | 70.01% |
| Dec 31, 2020 | -68.13% |